Tarsus Pharmaceuticals Inc (TARS)
Healthcare
Biotechnology
59.00 $
-0.8%
vs. previous close
Closing price · As of: 31. Jul 2026
Tarsus Pharmaceuticals Inc (TARS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -25 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -24 | -32 | -39 | -38 | -14 | -8.7 | -22 | -21 | -29 | 18 | 19 | -25 | -16 | |
| 0.2 | 0.2 | 0.3 | 0.3 | 0.2 | 0.3 | 0.4 | 0.5 | 0.5 | 0.4 | 0.4 | 0.4 | 1.7 | |
| 5.2 | 5.3 | 5.5 | 5.5 | 7.5 | 7.4 | 7.4 | 6.9 | 8.2 | 12 | 14 | 12 | 47 | |
| 5.2 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 3.1 | 1.4 | -2.8 | -8.6 | 10 | -1.7 | -5.7 | -1.9 | -16 | 19 | 14 | -29 | -13 | |
| 0.8 | 4.4 | 4.0 | 0.2 | 1.0 | 0.3 | 5.1 | 0.6 | 1.0 | 1.9 | 6.4 | 5.8 | 15 | |
| 64 | 47 | 18 | -102 | -41 | 3.1 | -60 | -35 | -52 | -4.7 | 49 | -59 | -66 | |
| 0.5 | – | – | – | -6.7 | 6.7 | – | – | – | – | – | – | – | |
| – | – | – | – | – | 0.0 | 0.0 | – | – | 0.0 | 0.0 | – | – | |
| 0.5 | 105 | 20 | 109 | 42 | 0.6 | 2.9 | 137 | 2.0 | 2.6 | 2.3 | 1.2 | 8.0 | |
| 41 | 120 | -1.7 | -31 | -13 | -4.9 | -79 | 81 | -79 | 16 | 71 | -82 | -74 | |
| -25 | -37 | -39 | -38 | -15 | -8.9 | -27 | -21 | -30 | 16 | 13 | -30 | -32 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.